Genotypic analysis of plasma HIV-1 RNA after influenza vaccination of patients with previously undetectable viral loads

AIDS

Volumn 16, Issue 4, 2002, Pages 537-542

  Kolber, Michael A ^a   Gabr, Abdel H ^a   De la Rosa, Abel ^a   Glock, Jonathan A ^a   Jayaweera, Dushyantha ^a   Miller, Nancimae ^a   Dickinson, Gordon M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; Healthcare; HIV resistance mutations; Influenza; LiPA; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; INFLUENZA VACCINE; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS RNA; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; INFLUENZA VACCINATION; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; VACCINATION; VIRUS GENOME; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIRAL LOAD;

EID: 0037040359     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200203080-00004     Document Type: Article

References (25)

1. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2. Effect of influenza vaccination in HIV-infected adults: A double-blind placebo-controlled trial
3. Activation of virus replication after vaccination of HIV-l-infected individuals
4. Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals
5. Influenza vaccination of human immunodeficiency virus (HIV)infected adults: Impact on plasma levels of HIV type 1 RNA and determinants of antibody response
6. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy
7. Respiratory viral infections in immunocompetent and immunocompromised persons
8. HIV-1 viraemia and influenza
9. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy
10. Effect of influenza vaccination on viral loads in HIV patients
11. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
12. Line probe assay for rapid detection of drug-selected mutations in the human ilmmunodeficlency virus type 1 reverse transcriptase gene
13. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy
14. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV Cohort Study
15. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
16. Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection
17. Antiretroviral resistance during successful therapy of HIV type I infection
18. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of point antiretroviral therapy
19. Prevalence and predictive value of intermittent viremia with combination HIV therapy
20. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged antiretroviral therapy
21. HIV-1 drug resistance profiles in children and adults with viral load of < 50 copies/ml receiving combination therapy
22. Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance
23. Divergent patterns of progression to AIDS after infection from the same source: Human immunodeficiency virus type 1 evolution and antiviral responses
24. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects
25. Effect of influenza vaccination on disease progression among HIV-infected persons. Adult and Adolescent Spectrum of HIV Disease Investigators